Dr. Schmid is head of the Pulmonary Aerosol Delivery Group at the Comprehensive Pneumology Center and Helmholtz Zentrum München (Munich, Germany) and he is Adjunct Assistant Professor at the Missouri University of Science and Technology (Rolla, MO, USA).
His current research interests range from health risks to diagnostic and therapeutic opportunities of respiratory aerosol. He has developed advanced methods for dosimetry and aerosol delivery to preclinical models of the lung and he is exploring in-vitro/in-vivo correlations in toxicology, efficacy and pharmacokinetics. He has published more than 80 peer-reviewed papers and book chapters, he has served on the boards of numerous professional associations, and he has been active as consultant to pharma industry and regulatory bodies.
The role of aerosols in preclinical drug development
